Skip to content

RevMAb

Recombinant monoclonal antibodies

RevMAb Biosciences USA is a biotechnology company focused on the development of recombinant monoclonal antibodies using a revolutionary technology that does not require cell fusion and hybridoma generation. The recombinant antibodies are developed from a broad range of antigen-specific B cells that are inaccessible to traditional hybridoma technology. This revolutionary method has successfully been applied to develop high quality recombinant rabbit and goat monoclonal antibodies.

 

Product Range:

  • anti-Histone antibodies / Histone modifications
  • Mutation specific antibodies against Histone mutations and other point mutations of other proteins
  • Mutations specific antibodies for Immunohistochemistry / IHC
  • Antibodies for immunohistochemistry
  • Pan-Protein modification antibodies
  • Secondary antibodies
  • Matched pair antibodies for the detection of human Ig classes and IgG Subclasses